Gelesis Holdings, Inc.
OTC: GLSHQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alessandro Sannino
- Employees
- 93
- Headquarters
- Boston, United States
- IPO year
- 2020
- Market cap
- $7.3K
- Website
- https://www.gelesis.com
Loading GLSHQ…
Loading profile data…Frequently asked questions about GLSHQ
What does Gelesis Holdings, Inc. (GLSHQ) do?
Gelesis Holdings, Inc. operated as a commercial-stage biotherapeutics company, concentrating on the development of biomimetic solutions. Its core mission revolved around addressing the root causes of obesity and various chronic gastrointestinal ailments. Among its offerings was PLENITY, an orally administered, non-stimulant, and non-systemic pro...
Where does GLSHQ trade?
Gelesis Holdings, Inc. (GLSHQ) trades on the Other OTC.
What sector is GLSHQ in?
Gelesis Holdings, Inc. (GLSHQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Gelesis Holdings, Inc.?
Alessandro Sannino is the chief executive officer of Gelesis Holdings, Inc. (GLSHQ).
Where is Gelesis Holdings, Inc. headquartered?
Gelesis Holdings, Inc. is headquartered in United States.
Does GLSHQ pay a dividend?
Gelesis Holdings, Inc. (GLSHQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GLSHQ go public?
Gelesis Holdings, Inc. (GLSHQ) completed its initial public offering in 2020.